Print Friendly

SENATE CONCURRENT RESOLUTION NO. 103

View Daily Data Tracking History

View Bill Text

View Statement of Purpose / Fiscal Impact

---

Text to be added within a bill has been marked with Bold and
Underline. Text to be removed has been marked with
Strikethrough and Italic. How these codes are actually displayed will
vary based on the browser software you are using.

This sentence is marked with bold and underline to show added text.

This sentence is marked with strikethrough and italic, indicating
text to be removed.

Daily Data Tracking History

---

SCR103................................................by HEALTH AND WELFARE
PHARMACY BOARD - RULES - Stating findings of the Legislature and rejecting
the Pharmacy Board administrative rule relating to the listing of the drug
carisoprodol.
                                                                        
02/01    Senate intro - 1st rdg - to printing
02/02    Rpt prt - to 10th Ord
02/05    3rd rdg - ADOPTED - voice vote
    title apvd - to House
02/06    House intro - 1st rdg - to Health/Wel
02/19    Rpt out - rec d/p - to 2nd rdg
02/20    2nd rdg - to 3rd rdg
02/22    3rd rdg - ADOPTED - 59-2-9
      AYES -- Barraclough, Barrett, Bedke, Bell, Bieter, Black, Bolz,
      Bradford, Bruneel, Callister, Campbell, Chase, Clark, Collins, Crow,
      Cuddy, Deal, Denney, Ellis, Ellsworth, Eskridge, Field(13),
      Field(20), Hadley, Harwood, Henbest, Higgins, Hornbeck, Jaquet,
      Jones, Kellogg, Kendell, Kunz, Lake, Loertscher, Mader, Marley,
      McKague, Meyer, Mortensen, Moss, Moyle, Pearce, Pischner, Pomeroy,
      Raybould, Roberts, Robison, Sali, Schaefer, Shepherd, Smith, Smylie,
      Stevenson, Stone, Tilman, Trail, Wheeler, Young
      NAYS -- Langford, Sellman
      Absent and excused -- Boe, Gagner, Gould, Hammond, Montgomery,
      Ridinger, Swan, Wood, Mr. Speaker
    Floor Sponsor -- Moyle
    Title apvd - to Senate
02/23    To enrol
02/26    Rpt enrol - Pres signed
02/27    Sp signed
02/28    To Secretary of State

Bill Text

                                                                        
                                                                        
  ||||              LEGISLATURE OF THE STATE OF IDAHO             ||||
 Fifty-sixth Legislature                  First Regular Session - 2001
                                                                        
                                                                        
                                       IN THE SENATE
                                                                        
                            SENATE CONCURRENT RESOLUTION NO. 103
                                                                        
                              BY HEALTH AND WELFARE COMMITTEE
                                                                        
  1                               A CONCURRENT RESOLUTION
  2    STATING FINDINGS OF THE LEGISLATURE AND REJECTING A CERTAIN RULE OF THE  IDAHO
  3        BOARD OF PHARMACY RELATING TO LISTING OF THE DRUG CARISOPRODOL.
                                                                        
  4    Be It Resolved by the Legislature of the State of Idaho:
                                                                        
  5        WHEREAS,  the  Legislature  is  vested  with authority to reject executive
  6    agency rules under the provisions of Section 67-5291, Idaho Code, in the event
  7    that the Legislature finds that the rules are not consistent with  legislative
  8    intent; and
  9        WHEREAS,  it  is  the finding of the Legislature that certain rules of the
 10    Idaho Board of Pharmacy relating to listing of the drug carisoprodol  are  not
 11    consistent with legislative intent and should be rejected.
 12        NOW, THEREFORE, BE IT RESOLVED by the members of the First Regular Session
 13    of  the Fifty-sixth Idaho Legislature, the Senate and the House of Representa-
 14    tives concurring therein, that IDAPA 27.01.01, Section  446  and  all  related
 15    subsequent  renumbering of the following sections, rules of the Idaho Board of
 16    Pharmacy relating to listing of the drug carisoprodol, adopted  as  a  pending
 17    rule  under  Docket  number 27-0101-0003, be, and the same are hereby rejected
 18    and declared null, void and of no force and effect.

Statement of Purpose / Fiscal Impact

                      STATEMENT OF PURPOSE
                                
                            RS 10699
                                
                                
                                
                                
At the request of the Idaho Board of Pharmacy, this concurrent
resolution would reject a pending rule of the Idaho Board of
Pharmacy relating to listing of the drug Carisoprodol. The effect
of this resolution, if adopted by both houses, would be to
prevent the agency rule from going into effect.


                          FISCAL NOTE
                                
This resolution would have no fiscal impact.



Contact:

Name: Senator Robbi Barrutia
Phone: (208) 332-1347


















STATEMENT OF PURPOSE/FISCAL NOTE                        SCR 103